Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;353(3):207-215.
doi: 10.1016/j.amjms.2016.12.013. Epub 2016 Dec 16.

Characterization of Mast Cell Activation Syndrome

Lawrence B Afrin  1 , Sally Self  2 , Jeremiah Menk  3 , John Lazarchick  2
Affiliations

Characterization of Mast Cell Activation Syndrome

Lawrence B Afrin et al. Am J Med Sci. 2017 Mar.

Abstract

Background: Mast cell activation syndrome (MCAS), a recently recognized nonneoplastic mast cell disease driving chronic multisystem inflammation and allergy, appears prevalent and thus important. We report the first systematic characterization of a large MCAS population.

Method: Demographics, comorbidities, symptoms, family histories, physical examination and laboratory findings were reviewed in 298 retrospective and 115 prospective patients with MCAS. Blood samples from prospective subjects were examined by flow cytometry for clonal mast cell disease and tested for cytokines potentially driving the monocytosis frequent in MCAS.

Results: Demographically, white females dominated. Median ages at symptom onset and diagnosis were 9 and 49 years, respectively (range: 0-88 and 16-92, respectively) and median time from symptom onset to diagnosis was 30 years (range: 1-85). Median numbers of comorbidities, symptoms, and family medical issues were 11, 20, and 4, respectively (range: 1-66, 2-84, and 0-33, respectively). Gastroesophageal reflux, fatigue and dermatographism were the most common comorbidity, symptom and examination finding. Abnormalities in routine laboratories were common and diverse but typically modest. The most useful diagnostic markers were heparin, prostaglandin D2, histamine and chromogranin A. Flow cytometric and cytokine assessments were unhelpful.

Conclusions: Our study highlights MCAS׳s morbidity burden and challenging heterogeneity. Recognition is important given good survival and treatment prospects.

Keywords: Chronic inflammatory diseases; Mast cell activation disease; Mast cell activation syndrome.

PubMed Disclaimer

Conflict of interest statement

Authorship and Conflict-of-Interest Statements

Dr. Afrin was the principal investigator and author and declares no conflicts of interest.

Dr. Self performed and interpreted the flow cytometry studies, reviewed the manuscript, and declares no conflicts of interest.

Mr. Menk performed statistical analyses, reviewed the manuscript, and declares no conflicts of interest.

Dr. Lazarchick performed and interpreted the cytokine analyses, reviewed the manuscript, and declares no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol. 2010;126:1099e4–1104e4. [PMID: 21035176] - PMC - PubMed
    1. Pejler G, Rönnberg E, Waern I, et al. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood. 2010;115:4981–4990. [PMID: 20233968] - PubMed
    1. Molderings GJ. Transgenerational transmission of systemic mast cell activation disease -- genetic and epigenetic features. Transl Res. 2016;174:86–97. [PMID: 26880691] - PubMed
    1. Molderings GJ, Homann J, Raithel M, et al. Toward a global classification of mast cell activation diseases. J Allergy Clin Immunol. 2011;127:1311. author reply 1311–2 [PMID: 21306766] - PubMed
    1. Haenisch B, Nöthen MM, Molderings GJ. Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunol. 2012;137:197–205. [PMID: 22957768] - PMC - PubMed

Publication types

MeSH terms